Shanghai Microport Ep Medtech Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2010-08-31
- Employees
- 577
- Market Cap
- -
- Website
- http://www.everpace.com
Clinical Trials
5
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (100.0%)A Clinical Study on the Use of a Domestically Produced Three-dimensional Cardiac Electrophysiological Mapping System Combined With Pressure Monitoring Technology and Star Mapping Technology for the Treatment of Paroxysmal Atrial Fibrillation.
Not Applicable
Not yet recruiting
- Conditions
- Paroxysmal Atrial Fibrillation (PAF)
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT07039032
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
A Clinical Study on the Use of a Domestically Produced Cryoablation System Combined With Balloon Cryoablation Technology for the Treatment of Paroxysmal Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- Paroxysmal Atrial Fibrillation (PAF)
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT07036068
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function
Not Applicable
Not yet recruiting
- Conditions
- Rapid ArrhythmiaAtrial Fibrillation (AF)Paroxysmal Supraventricular Tachycardia (PSVT)
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT07032948
A Dual Energy Catheter (PFA and RFA) and a PFA Catheter for the Treatment of PeAF
Not Applicable
Completed
- Conditions
- Persistent Atrial Fibrillation
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06232798
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia
Not Applicable
Completed
- Conditions
- Paroxysmal Supraventricular TachycardiaAtrioventricular Nodal Reentrant TachycardiaAtrioventricular Reciprocating Tachycardia
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
- Target Recruit Count
- 164
- Registration Number
- NCT05820035
- Locations
- 🇨🇳
The First Affiliated Hospital of Ningbo University (original name :Ningbo First Hospital), Ningbo, Zhejiang, China
News
Stereotaxis' Magbot Magnetic Ablation Catheter Approved in China
Stereotaxis received regulatory approval in China for its Magbot magnetic navigation ablation catheter, designed for minimally invasive cardiac procedures.